Atossa Genetics Stock Performance
| ATOS Stock | USD 0.62 0.06 8.82% |
The firm shows a Beta (market volatility) of 1.92, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Atossa Genetics will likely underperform. At this point, Atossa Genetics has a negative expected return of -0.5%. Please make sure to confirm Atossa Genetics' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Atossa Genetics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Atossa Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 88.6 M | |
| Total Cashflows From Investing Activities | -19 K | |
| Free Cash Flow | -21 M |
Atossa Genetics Relative Risk vs. Return Landscape
If you would invest 89.00 in Atossa Genetics on October 31, 2025 and sell it today you would lose (27.00) from holding Atossa Genetics or give up 30.34% of portfolio value over 90 days. Atossa Genetics is currently does not generate positive expected returns and assumes 4.3167% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than Atossa, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Atossa Genetics Target Price Odds to finish over Current Price
The tendency of Atossa Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.62 | 90 days | 0.62 | about 90.09 |
Based on a normal probability distribution, the odds of Atossa Genetics to move above the current price in 90 days from now is about 90.09 (This Atossa Genetics probability density function shows the probability of Atossa Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.92 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Atossa Genetics will likely underperform. Additionally Atossa Genetics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Atossa Genetics Price Density |
| Price |
Predictive Modules for Atossa Genetics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Atossa Genetics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Atossa Genetics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Atossa Genetics is not an exception. The market had few large corrections towards the Atossa Genetics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Atossa Genetics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Atossa Genetics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.61 | |
β | Beta against Dow Jones | 1.92 | |
σ | Overall volatility | 0.09 | |
Ir | Information ratio | -0.13 |
Atossa Genetics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Atossa Genetics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Atossa Genetics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Atossa Genetics generated a negative expected return over the last 90 days | |
| Atossa Genetics has some characteristics of a very speculative penny stock | |
| Atossa Genetics has high historical volatility and very poor performance | |
| Net Loss for the year was (25.5 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Atossa Genetics currently holds about 125.54 M in cash with (21.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.99, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Atossa Genetics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Atossa Stock often depends not only on the future outlook of the current and potential Atossa Genetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Atossa Genetics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 125.9 M | |
| Cash And Short Term Investments | 71.1 M |
Atossa Genetics Fundamentals Growth
Atossa Stock prices reflect investors' perceptions of the future prospects and financial health of Atossa Genetics, and Atossa Genetics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Atossa Stock performance.
| Return On Equity | -0.49 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | 36.61 M | |||
| Shares Outstanding | 129.17 M | |||
| Price To Earning | (0.62) X | |||
| Price To Book | 1.78 X | |||
| EBITDA | (27.6 M) | |||
| Cash And Equivalents | 125.54 M | |||
| Cash Per Share | 0.99 X | |||
| Total Debt | 4.97 M | |||
| Book Value Per Share | 0.39 X | |||
| Cash Flow From Operations | (21.03 M) | |||
| Earnings Per Share | (0.23) X | |||
| Total Asset | 76.44 M | |||
| Retained Earnings | (211.79 M) | |||
| Current Asset | 4.29 M | |||
| Current Liabilities | 2.5 M | |||
About Atossa Genetics Performance
Assessing Atossa Genetics' fundamental ratios provides investors with valuable insights into Atossa Genetics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Atossa Genetics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington. Atossa Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.Things to note about Atossa Genetics performance evaluation
Checking the ongoing alerts about Atossa Genetics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Atossa Genetics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Atossa Genetics generated a negative expected return over the last 90 days | |
| Atossa Genetics has some characteristics of a very speculative penny stock | |
| Atossa Genetics has high historical volatility and very poor performance | |
| Net Loss for the year was (25.5 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Atossa Genetics currently holds about 125.54 M in cash with (21.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.99, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Atossa Genetics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Atossa Genetics' stock is overvalued or undervalued compared to its peers.
- Examining Atossa Genetics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Atossa Genetics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Atossa Genetics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Atossa Genetics' stock. These opinions can provide insight into Atossa Genetics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.